https://www.selleckchem.com/pr....oducts/Fludarabine(F
001). The objective and subjective cure rates were comparable after SIS and TOS procedures (objective 76% vs. 76%, p = 0.837; subjective 78% vs. 83%, p = 0.212). There were no significant differences in adverse events, except SISs had a shorter surgery time (16.4 ± 9.3 vs. 27.3 ± 12.4min, p = 0.02 and lower postoperative visual analog scale pain score (1.3 ± 1.1 vs. 3.9 ± 1.4, p 0.001). SISs and TOSs had similar surgical results in women with stress incontinence and ISD after at least 1year of follow-up. However, SIS